Clinical Trial Update: Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Vincristine, Dactinomycin, and Cyclophosphamide for embryonal rhabdomyosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Embryonal Rhabdomyosarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Dactinomycin (dactinomycin)
• Vincristine (vincristine)

Snippet

Sponsor: Japan Rhabdomyosarcoma Study Group | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN